Search Results

BioSpace has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.

Cambrian BioPharma , a multi-asset longevity biotech, today unveils its latest pipeline company, Isterian Biotech.

Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.

Job security is a hot topic among biopharma professionals. A career coach offers advice for how to evaluate and build it up and what to do if that evaluation leaves you worried.

Cambrian BioPharma, a multi-asset longevity biotech, today announces the appointment of Ruth Thieroff-Ekerdt, M.D., as Executive Vice President of Clinical Development.

Cambrian Biopharma announced that its latest pipeline company, Isterian Biotech, has emerged from stealth to develop first-in-class medicines to tackle aging.

Cambrian BioPharma, a multi-asset longevity biotech, announces its Scientific Advisory Board and appointment of C. David Nicholson, PhD and Frank S. Walsh, PhD to lead.

Cambrian BioPharma announced that its CEO, James Peyer, has been selected as “BioTech Company CEO of the Year” in the second annual BioTech Breakthrough Awards, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe.

Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging, announced the launch of its new pipeline company, Telos Biotech.